DTIL · Precision Biosciences Inc
United States · RS rating 64 · As of 2026-11-03
| Price | 6.97 USD |
|---|---|
| 1-day change | +0.3% |
| RS rating (overall / 1M / 3M / 12M) | 64 / 83 / 52 / 40 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 40 / 30 / 59 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +157.1% |
| Sales growth Q/Q | +263007.7% |
| Distance from 52-week high | +24.9% |
| Market cap (USD) | $188.6M |